Polymethoxylated flavones for treating insulin resistance

摘要

Compositions and methods for treating metabolic abnormalities arising from insulin resistance comprises the administration of trangeretin or a mixture of various polymethoxylated flavones (PMF's) are described. The PMF's are administered in various manners including orally. Supplementation with PMF's to individuals affected by insulin resistance syndrome results in normalization of metabolic activity and improved glucose metabolism.